Treatment with antidepressant medications in private health plans

被引:18
|
作者
Larson, Mary Jo
Miller, Kay
Fleming, Kathleen J.
机构
[1] New England Res Inst Inc, Inst Hlth Serv Res, Watertown, MA 02472 USA
[2] Medstat, Santa Barbara, CA 93111 USA
[3] New England Res Inst Inc, Watertown, MA USA
关键词
antidepressants; utilization; expenditures; private insurance;
D O I
10.1007/s10488-006-0088-5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This study analyzed 2002 MarketScan data from a convenience sample of enrollees with private health insurance from the largest U.S. firms to examine utilization, expenditures, and factors associated with antidepressant prescriptions. Of enrollees, 11% received at least one antidepressant prescription during the year with average expenditures per enrollee of $51.55. Antidepressant prescriptions were more frequently used than any form of other mental health care and for 42% of users was not associated with any clearly identified mental health or "off-label" indication. In logistical regression analyses, health plan type, prescription days supply, gender, region, age, employment status, and subscriber status were associated with unexplained antidepressant prescription use.
引用
收藏
页码:116 / 126
页数:11
相关论文
共 50 条
  • [31] Behavioral Health Services in the Changing Landscape of Private Health Plans
    Horgan, Constance M.
    Stewart, Maureen T.
    Reif, Sharon
    Garnick, Deborah W.
    Hodgkin, Dominic
    Merrick, Elizabeth L.
    Quinn, Amity E.
    PSYCHIATRIC SERVICES, 2016, 67 (06) : 621 - 628
  • [32] COSTS OF ANTIDEPRESSANT MEDICATIONS
    CLARK, DB
    JOURNAL OF CLINICAL PSYCHIATRY, 1995, 56 (09) : 432 - 432
  • [33] Antidepressant medications in children
    Vitiello, B
    Swedo, S
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15): : 1489 - 1491
  • [34] Antidepressant medications in pregnancy
    Huntington, J
    Zantop, V
    AMERICAN FAMILY PHYSICIAN, 2004, 70 (11) : 2195 - 2196
  • [35] CONTRASTS IN ANTIDEPRESSANT MEDICATIONS
    WITTENBORN, JR
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 : S153 - S156
  • [36] Antidepressant medications and osteoporosis
    Rizzoli, R.
    Cooper, C.
    Reginster, J. -Y.
    Abrahamsen, B.
    Adachi, J. D.
    Brandi, M. L.
    Bruyere, O.
    Compston, J.
    Ducy, P.
    Ferrari, S.
    Harvey, N. C.
    Kanis, J. A.
    Karsenty, G.
    Laslop, A.
    Rabenda, V.
    Vestergaard, P.
    BONE, 2012, 51 (03) : 606 - 613
  • [37] Influence of Antidepressant Treatment on Use of and Adherence to COPD Maintenance Medications
    Wei, Yu-Jung Jenny
    Simoni-Wastila, Linda
    Albrecht, Jennifer S.
    Huang, Ting-Ying
    Moyo, Patience
    Khokha, Bilal
    Harris, Ilene
    Langenberg, Patricia
    Netzer, Giora
    Lehmann, Susan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 53 - 53
  • [38] Rationale for using two antidepressant medications for treatment initiation in depression
    Blier, Pierre
    SOUTH AFRICAN JOURNAL OF PSYCHIATRY, 2007, 13 (01) : 26 - 26
  • [39] Comparative Effectiveness of TMS and Antidepressant Medications in the Treatment of Major Depression
    Demitrack, Mark Andrew
    Bonneh-Barkay, Dafna
    Brock, David G.
    Waltman, Angela
    Nahas, Ziad
    Simpson, Kit N.
    Simpson, Annie N.
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 256S - 257S
  • [40] Medications requiring prior authorization across health insurance plans
    Jones, Laney K.
    Ladd, Ilene G.
    Gionfriddo, Michael R.
    Gregor, Christina
    Evans, Michael A.
    Graham, Jove
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2020, 77 (08) : 644 - 648